Literature DB >> 2155557

Inositol phosphate metabolism and signal transduction.

A R Hughes1, D A Horstman, H Takemura, J W Putney.   

Abstract

Activation of a variety of cell surface receptors results in a biphasic increase in the cytoplasmic Ca2+ concentration, due to the release or mobilization of intracellular Ca2+ stores and to the entry of Ca2+ from the extracellular space. Stimulation of these same receptors also results in the hydrolysis of the minor plasma membrane phospholipid, phosphatidylinositol 4,5-bisphosphate, with the concomitant formation of (1,4,5)inositol trisphosphate [(1,4,5)IP3] and diacylglycerol. It is well established that phosphatidylinositol 4,5-bisphosphate hydrolysis is responsible for the changes in Ca2+ homeostasis. There is strong evidence that (1,4,5)IP3 stimulates Ca2+ release from intracellular stores. The Ca2(+)-releasing actions of (1,4,5)IP3 are terminated by its metabolism through two distinct pathways: (1,4,5)IP3 is dephosphorylated by a 5-phosphatase to (1,4)IP2; alternatively, (1,4,5)IP3 is phosphorylated to (1,3,4,5)IP4 by a 3-kinase. Whereas the mechanism of Ca2+ mobilization is understood, the precise mechanisms involved in Ca2+ entry are not known. A recent proposal that (1,4,5)IP3, by emptying an intracellular Ca2+ pool, secondarily elicits Ca2+ entry will be considered. This review summarizes recent studies of the mechanisms by which inositol phosphates regulate cytoplasmic Ca2+ concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155557     DOI: 10.1164/ajrccm/141.3_Pt_2.S115

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  2 in total

1.  An integrated proteomics analysis of bone tissues in response to mechanical stimulation.

Authors:  Jiliang Li; Fan Zhang; Jake Y Chen
Journal:  BMC Syst Biol       Date:  2011-12-23

2.  PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol.

Authors:  Giovanni Monastra; Ivana Vucenik; Abdel Halim Harrath; Saleh H Alwasel; Zdravko A Kamenov; Antonio Simone Laganà; Noemi Monti; Valeria Fedeli; Mariano Bizzarri
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-06       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.